GFAP and Alzheimer disease: Researchers recently identified new biomarkers in the blood that can be detected up to 10 years before the onset of AD’s symptoms, one of these being GFAP (glial fibrillary acidic protein) [59,60,61] which can be regulated by probiotics intake in animal models [62].